iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
 
 
GSK2336805 NS5A
 
 
  GSK2336805 HCV NS5A Inhibitor Demonstrates Potent Antiviral Activity in Chronic Hepatitis C (CHC) Genotype 1 Infection: Results from a First Time in Human (FTIH) Single and Repeat Dose Study http://www.natap.org/2011/AASLD/AASLD_30.htm
 
In vitro profiling of GSK2336805, A Potent and Selective Inhibitor of HCV NS5A http://www.natap.org/2011/EASL/EASL_74.htm
 
Phase 2 study:
Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects http://clinicaltrials.gov/show/NCT01439373
 
ABT-450 - active against all genotypes 1-6, preferentially 1 and 4
ABT-267 - pangenotypic
ABT-333/072 - genotype 1 only
 
A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-267 and With and Without Ribavirin (RBV) in Treatment-Na•ve Subjects With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)

Table1.gif

  
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org